ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/22 | 1,141 | 1,145 | 1,127 | 1,132 | -5 | -0.4% | 370,400 |
| 2024/11/21 | 1,131 | 1,146 | 1,124 | 1,137 | +17 | +1.5% | 617,200 |
| 2024/11/20 | 1,110 | 1,122 | 1,103 | 1,120 | +16 | +1.4% | 499,200 |
| 2024/11/19 | 1,115 | 1,128 | 1,100 | 1,104 | -15 | -1.3% | 1,328,000 |
| 2024/11/18 | 1,163 | 1,167 | 1,119 | 1,119 | -47 | -4% | 918,400 |
| 2024/11/15 | 1,167 | 1,177 | 1,155 | 1,166 | +3 | +0.3% | 466,400 |
| 2024/11/14 | 1,177 | 1,184 | 1,161 | 1,163 | -12 | -1% | 450,000 |
| 2024/11/13 | 1,200 | 1,200 | 1,174 | 1,175 | -27 | -2.2% | 621,300 |
| 2024/11/12 | 1,237 | 1,254 | 1,199 | 1,202 | +8 | +0.7% | 1,345,300 |
| 2024/11/11 | 1,192 | 1,198 | 1,176 | 1,194 | -3 | -0.3% | 332,100 |
| 2024/11/08 | 1,195 | 1,209 | 1,191 | 1,197 | +5 | +0.4% | 470,700 |
| 2024/11/07 | 1,195 | 1,203 | 1,174 | 1,192 | -8 | -0.7% | 646,300 |
| 2024/11/06 | 1,189 | 1,222 | 1,179 | 1,200 | +26 | +2.2% | 724,600 |
| 2024/11/05 | 1,230 | 1,256 | 1,169 | 1,174 | -39 | -3.2% | 862,400 |
| 2024/11/01 | 1,200 | 1,221 | 1,200 | 1,213 | -16 | -1.3% | 567,700 |
| 2024/10/31 | 1,205 | 1,229 | 1,201 | 1,229 | +22 | +1.8% | 480,800 |
| 2024/10/30 | 1,213 | 1,214 | 1,198 | 1,207 | -3 | -0.2% | 526,700 |
| 2024/10/29 | 1,185 | 1,213 | 1,180 | 1,210 | +24 | +2% | 444,300 |
| 2024/10/28 | 1,150 | 1,188 | 1,146 | 1,186 | +30 | +2.6% | 469,300 |
| 2024/10/25 | 1,179 | 1,182 | 1,141 | 1,156 | -33 | -2.8% | 608,600 |
| 2024/10/24 | 1,150 | 1,190 | 1,125 | 1,189 | +32 | +2.8% | 923,900 |
| 2024/10/23 | 1,180 | 1,182 | 1,157 | 1,157 | -21 | -1.8% | 376,500 |
| 2024/10/22 | 1,217 | 1,218 | 1,175 | 1,178 | -53 | -4.3% | 488,900 |
| 2024/10/21 | 1,198 | 1,247 | 1,197 | 1,231 | +26 | +2.2% | 991,900 |
| 2024/10/18 | 1,180 | 1,211 | 1,174 | 1,205 | +35 | +3% | 589,000 |
| 2024/10/17 | 1,158 | 1,174 | 1,148 | 1,170 | +11 | +0.9% | 595,200 |
| 2024/10/16 | 1,178 | 1,183 | 1,145 | 1,159 | -43 | -3.6% | 1,074,000 |
| 2024/10/15 | 1,184 | 1,218 | 1,182 | 1,202 | +26 | +2.2% | 1,350,200 |
| 2024/10/11 | 1,193 | 1,193 | 1,174 | 1,176 | -23 | -1.9% | 432,300 |
| 2024/10/10 | 1,194 | 1,199 | 1,176 | 1,199 | +2 | +0.2% | 563,500 |
| 2024/10/09 | 1,200 | 1,212 | 1,187 | 1,197 | +7 | +0.6% | 589,800 |
| 2024/10/08 | 1,230 | 1,235 | 1,183 | 1,190 | -61 | -4.9% | 1,239,200 |
| 2024/10/07 | 1,281 | 1,281 | 1,251 | 1,251 | -22 | -1.7% | 502,600 |
| 2024/10/04 | 1,265 | 1,284 | 1,264 | 1,273 | +6 | +0.5% | 348,100 |
| 2024/10/03 | 1,234 | 1,276 | 1,221 | 1,267 | +51 | +4.2% | 741,400 |
| 2024/10/02 | 1,230 | 1,247 | 1,211 | 1,216 | -10 | -0.8% | 670,500 |
| 2024/10/01 | 1,234 | 1,240 | 1,212 | 1,226 | -6 | -0.5% | 739,300 |
| 2024/09/30 | 1,255 | 1,281 | 1,224 | 1,232 | -65 | -5% | 1,199,700 |
| 2024/09/27 | 1,313 | 1,320 | 1,288 | 1,297 | -11 | -0.8% | 561,200 |
| 2024/09/26 | 1,289 | 1,308 | 1,285 | 1,308 | +27 | +2.1% | 698,000 |
| 2024/09/25 | 1,310 | 1,314 | 1,281 | 1,281 | -32 | -2.4% | 605,100 |
| 2024/09/24 | 1,331 | 1,337 | 1,304 | 1,313 | -18 | -1.4% | 574,100 |
| 2024/09/20 | 1,350 | 1,357 | 1,327 | 1,331 | +9 | +0.7% | 1,050,600 |
| 2024/09/19 | 1,308 | 1,326 | 1,304 | 1,322 | +23 | +1.8% | 505,800 |
| 2024/09/18 | 1,279 | 1,299 | 1,273 | 1,299 | +34 | +2.7% | 557,100 |
| 2024/09/17 | 1,305 | 1,317 | 1,237 | 1,265 | -33 | -2.5% | 1,009,600 |
| 2024/09/13 | 1,330 | 1,335 | 1,287 | 1,298 | -43 | -3.2% | 766,900 |
| 2024/09/12 | 1,321 | 1,342 | 1,305 | 1,341 | +50 | +3.9% | 671,900 |
| 2024/09/11 | 1,295 | 1,310 | 1,276 | 1,291 | +8 | +0.6% | 887,700 |
| 2024/09/10 | 1,285 | 1,294 | 1,270 | 1,283 | +1 | +0.1% | 569,600 |
1～
50
件表示中 / 4976件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
